[en] Objective: In experimental animals, recent results suggest that the addition of inulin-type fructans such as oligofructose (OFS) in the diet decreases triacylglycerol accumulation in the liver tissue. Therefore, we have investigated the effect of daily ingestion of OFS in seven patients with nonalcoholic steatohepatitis (NASH), confirmed by liver biopsies.
Design: They received 16 g/day OFS or maltodextrine (placebo) for 8 weeks in a randomized double-blind crossover design. Energy intake, body composition, liver steatosis and blood parameters were analysed after 4 and 8 weeks of dietary supplementation.
Results: Compared to placebo, OFS decreased significantly serum aminotransferases, aspartate aminotransferase after 8 weeks, and insulin level after 4 weeks, but this could not be related to significant effect on plasma lipids.
Conclusion: This pilot study supports the putative interest of OFS in the management of liver diseases associated with abnormal lipid accumulation in humans.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Daubioul, C. A.
Horsmans, Y.
Lambert, Philippe ; Université de Liège - ULiège > Institut des sciences humaines et sociales > Méthodes quantitatives en sciences sociales
Danse, E.
Delzenne, N. M.
Language :
English
Title :
Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis : results of a pilot study
Agrawal S & Bonkovsky HL (2002): Management of nonalcoholic steatohepatitis: an analytic review. J. Clin. Gastroenterol. 35, 253-261.
Bergman RN, Van Citters GW, Mittelman SD, Dea MK, Hamilton-Wessler M, Kim SP & Ellmerer M (2001): Central role of the adipocyte in the metabolic syndrome. J. Investig. Med. 49, 119-126.
Brighenti E Casiraghi MC, Canzi E & Ferrari A (1999): Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal motility and blood lipids in healthy male volunteers. Eur. J. Clin. Nutr. 53, 726-733.
Brunt EM, Janney CG, Di Bisceglie AM, Neuschwandef-Tetri BA & Bacon BR (1999): Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 94, 2467-2474.
Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, Hui JM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, Weltman M & George J (2002): NASH and insulin resistance: insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 35, 373-379.
Daubioul CA, Rousseau N, Demeure R, Gallez B, Taper HS, Declerck B & Delzenne NM (2002): Dietary fructans, but not cellulose, decrease triglyceride accumulation in the liver of obese Zucker fa/fa rats. J. Nutr. 132, 967-973.
Daubioul CA, Taper HS, De Wispelaere LD & Delzenne NM (2000): Dietary oligofructose lessens hepatic steatosis, but does not prevent hypertriglyceridemia in obese Zucker rats. J. Nutr. 130, 1314-1319.
Delzenne NM & Williams CM (2002): Prebiotics and lipid metabolism. Curr. Opin. Lipidol. 13, 61-67.
Diraison F, Moulin P & Beylot M (2003): Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non alcoholic fatty liver disease. Diabetes Metab. 29, 478-485.
Jackson KG, Taylor GR, Clohessy AM & Williams C (1999): The effect of daily intake of inulin on fasting lipid, insulin and glucose concentrations in middle-aged men and women. Br. J. Nutr. 82, 23-30.
Kok N, Roberfroid M & Delzenne N (1996): Dietary OFS modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism 45, 1547-1550.
Letexier D, Diraison F & Beylot M (2003): Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J. Clin. Nutr. 77, 559-564.
Luyck FH, Lefebvre PJ & Scheen AJ (2000): Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab. 26, 98-106.
Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N, Cassader M, David E, Cavallo-Perin P & Rizzetto M (2002): Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome : further evidence for an etiologic association. Hepatology 35, 367-372.
